Free Trial
OTCMKTS:GNMLF

Genomma Lab Internacional (GNMLF) Stock Price, News & Analysis

$1.14 0.00 (0.00%)
As of 05/30/2025

About Genomma Lab Internacional Stock (OTCMKTS:GNMLF)

Key Stats

Today's Range
$1.14
$1.14
50-Day Range
$1.09
$1.43
52-Week Range
$0.93
$1.43
Volume
315,000 shs
Average Volume
1,900 shs
Market Capitalization
N/A
P/E Ratio
0.67
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

Genomma Lab Internacional Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
13th Percentile Overall Score

GNMLF MarketRank™: 

Genomma Lab Internacional scored higher than 13% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Genomma Lab Internacional.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Genomma Lab Internacional is 0.67, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.28.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Genomma Lab Internacional is 0.67, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 27.05.

  • Read more about Genomma Lab Internacional's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Genomma Lab Internacional has a short interest ratio ("days to cover") of 908.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Genomma Lab Internacional has recently decreased by 40.28%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Genomma Lab Internacional does not currently pay a dividend.

  • Dividend Growth

    Genomma Lab Internacional does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Genomma Lab Internacional has a short interest ratio ("days to cover") of 908.8, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Genomma Lab Internacional has recently decreased by 40.28%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Genomma Lab Internacional has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Genomma Lab Internacional this week, compared to 0 articles on an average week.
Receive GNMLF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genomma Lab Internacional and its competitors with MarketBeat's FREE daily newsletter.

GNMLF Stock News Headlines

Dalio heeds Buffett’s warning… [$319 million stake in gold]
Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profitable miners selling at deep discounts. I call this price gap the Golden Anomaly — and I’ve put together a full report on my top four picks.
See More Headlines

GNMLF Stock Analysis - Frequently Asked Questions

Genomma Lab Internacional's stock was trading at $1.27 at the beginning of the year. Since then, GNMLF shares have decreased by 10.2% and is now trading at $1.14.
View the best growth stocks for 2025 here
.

Shares of GNMLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
6/01/2025
Next Earnings (Estimated)
7/22/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
OTCMKTS:GNMLF
CIK
N/A
Fax
N/A
Employees
1,614
Year Founded
N/A

Profitability

Trailing P/E Ratio
0.67
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for June 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (OTCMKTS:GNMLF) was last updated on 6/1/2025 by MarketBeat.com Staff
From Our Partners